PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers

Clinical trial NCT05162053 · COMPLETED

Trial details

NCT number: NCT05162053
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2021-12-09
Primary completion: 2022-11-03
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.